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Abstract 
Purpose: To explore the effect of Paeonia lactiflora Pall. extract on depression in rats. 
Methods: Various doses (150, 300 and 600 mg/kg) of Paeonia lactiflora Pall. extract (PLPE) were orally 
administered to three groups of rats of 10 each, respectively, suffering from depression for 14 days. 
Fluoxetine was used as positive control. Tail suspension, forced swimming and monoamine oxidase 
(MAO) tests were carried out on the rats.  
Results: A dose-dependent reduction in rat immobility was observed. The effect of PLPE at the highest 
dose (600 mg/kg) was more potent than that of the reference antidepressant, fluoxetine. PLPE, at a 
dose ≥ 150 mg/kg significantly inhibited MAO A activity in rat whole brain in a dose-dependent manner 
(p < 0.01); however, only oral administration of PLPE at a dose of 600 mg/kg produced observable MAO 
B inhibitory activity in rat brain (p < 0.01). Only fluoxetine showed a tendency to inhibit both MAO A and 
B activities in animal brain. Neither PLPE nor fluoxetine, at the doses tested, produced significant 
effects on locomotor activity.  
Conclusion: The results suggest that Paeonia lactiflora Pall is a potential agent for the treatment of 
depression in humans. 
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Depression is a major disease affecting nearly 13 
- 20 % of the population [1]. In spite of the 
introduction of the tricyclic antidepressants 
(TCAs), selective reversible inhibitors of 
monoamine oxidize A (RIMAs), selective 
serotonin reuptake inhibitors (SSRIs) and 
specific serotonin-noradrenaline reuptake 
inhibitors (SNRIs), depression continues to be a 
major medical problem. However, search for new 
antidepressant drug continues. According to the 
theory of the traditional Chinese medicine (TCM), 
the clinical condition of depression could be 
mainly classified into liver qi stagnation, the 
symptom of which can be described as mental 
stress, hypochondriac distensive pain, or lumps 
in the breasts, hernial pain and irregular 
menstruation. Based on this, many Chinese 
medicinal plants were successfully used to 
manage the disorder of depression by dispersing 
stagnant liver qi and the active principles from 
some of them were isolated [2,3]. 
 
Paeonia lactiflora Pall. is a well-known 
indigenous herbal medicine for treating 
depression in China. In the present study, we 
examined the in vivo antidepressant activities of 
Paeonia lactiflora Pall. extract in rat models of 
immobility tests as well as MAO activity in rat 
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whole brain in comparison with the effects of a 






The herbal samples of Paeonia lactiflora Pall. 
were collected from Shiyan City, Hubei Province 
in China in October 2015. Taxonomic 
identification of the plant was performed by 
Professor Li Hu of Dalian University in China. A 
voucher specimen of herbarium (no. PLPE 
20151008) was deposited in the herbarium of 
College of Pharmacy, Dalian University, China 
for future reference. The PLPE was obtained by 
steeping the dried Paeonia lactiflora Pall. in 
water at 60 oC three times, each for one hour 
before first drying in an oven and then freeze-
drying the last extract thus obtained. One gram 
powder was equivalent to about 1.5 g crude 




Sprague Dawley rats, weighing 180 - 220 g, were 
provided by the Experimental Animal Center of 
Liaoning Province (Certificate no. SYXK 2001-
0005). The animals had free access to food and 
water, and were allowed to acclimatize for at 
least one week before use. The rat experiment 
was approved by the Animal Care and Use 
Committee of Dalian University (approval ref no. 
20130602) and was carried out in compliance 
with Directive 2010/63/EU on the handling of 
animals used for scientific purposes [4]. 
 
Animal group  
 
The female rats were randomly divided into 5 
groups of ten rats: control group [normal saline 
(0.9 % NaCl)], reference group (fluoxetine 30 
mg/kg) as well as the PLPE groups, namely, 150, 
300 and 600 mg/kg doses. All drugs were orally 
administered at 14: 00-15: 00 h every day for 14 
days, respectively. The behavioral tests were 
conducted 1 h after the last treatment. MAO 
assay was started in rats 1 h was administered 
after 14-day administration. 
 
Tail suspension test 
 
The tail suspension test was based on the 
method of Steru [5]. Rats were individually 
suspended by the tail with a clamp (1 cm distant 
from the end) for 6 min in a box with the head 5 
cm to the bottom. Testing was carried out in a 
darkened room with minimal background noise. 
The duration of immobility was observed during 
the final 4 min interval of the test. 
 
Forced swimming test 
 
Before drugs were administrated, rats were 
forced to swim individually for 6 min, in glass 
cylinders (20 cm in height; 14 cm in diameter), 
containing fresh water up to a height of 10 cm at 
25 o̊C. After 6 min, they were removed and dried 
with a towel. They were again forced to swim in a 
similar environment for a period of 6 min 24 h 
later. The duration of immobility was measured 




The mitochondrial fraction suspended in 10 
milliliter of cold sodium phosphate buffer (10 mM, 
pH 7.4, containing 320 mM sucrose), was 
mingled at 4 o̊C for 20 min. The mixture was 
centrifuged at 15 000 ×/g for 30 min at 0 o̊C and 
the pellets were re-suspended in the same 
buffer. The protein concentration was adjusted to 
1 mg/ml. Protein concentrationwas estimated by 
the Lowry method [6] using bovine serum 
albumin as thestandard. MAO activity was 
assessed as described previously [7]. The assay 
mixtures contained 4 mM 5-HT or 2mMb-PEA as 
specific substrates for MAO A and B, 
respectively, 250 ml solution of the mitochondrial 
fraction and 100 mM sodium phosphate buffer 
(pH 7.4) upto a final volume of 1 ml. The reaction 
was allowed to proceed at 37 oC for 20 min, and 
stopped by adding 1 M HCl (200 ml), the reaction 
product was extracted with 5 ml of butyl acetate 
(for MAO A assay) or cyclohexane (for MAO B 
assay), respectively. The organic phase was 
measured at wavelength of 280 nm for MAO A 
assay and 242 nm for MAO B assay with 
spectrophotometer respectively. Blank samples 
were prepared by adding 1 M HCl (200 ml) prior 





Data are expressed as mean ± standard 
deviation (SD). Significant differences between 
the groups were analyzed using one-way 
analysis of variance (ANOVA) followed by two-





Effect of PLPE on duration of immobility  
 
As shown in Table 1, PLPE showed no change 
after 1 day treatment, and had the tendency to 
reduce the immobility time only after 7-day 
treatment. After a 14-day treatment, PLPE at the 
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doses of 150, 300 and 600 mg/kg significantly 
decreased the duration of immobility in a dose-
dependent manner, resulting in 33.4, 41.5 and 
56.3 % immobility reduction, respectively (p < 
0.05). However, the reference antidepressant 
fluoxetine at the dose of 30 mg/kg resulted in 
reduction. PLPE at the doses of 300 and 600 
mg/kg appeared to be more potent than that of 
fluoxetine after 14-day treatment in the study. 
 
As shown in Table 2, PLPE showed no change 
after 1 day treatment. PLPE at the dose of 600 
mg/kg exhibited a reduction in immobility after 7-
day treatment (p < 0.05). The extract at all doses 
tested decreased the duration of immobility in a 
dose-dependent manner, resulting in 51.3, 61.4 
and 67.8 % immobility reduction for the 150, 300 
and 600 mg/kg after 14-day treatment, 
respectively. Fluoxetine at the dose of 30 mg/kg 
significantly produced a time-dependent 
immobility reduction. PLPE at the dose of 600 
mg/kg appeared to be more potent than that of 
fluoxetine after 14-day treatment. 
 
Effect of PLPE on MAO A and B activities in 
rat whole brain 
 
The effect of PLPE and fluoxetine for 14 days on 
the MAO A and B activities in rat whole brain is 
shown in Table 3. The MAO A and B activities in 
normal group were 24.8 ±/1.6 nmol/mg protein h 
and 20.4 ± 1.3 nmol/mg protein h, respectively. 
Oral administration of the extract at the doses of 
150, 300 and 600 mg/kg inhibited MAO A activity 
in a dose-dependent manner, providing 21.6, 
34.7 and 44.3 % inhibition (p < 0.05). However, 
only the extract at a dose of 600 mg/kg inhibited 
MAO B activity, producing 35.4 % inhibition (p < 
0.05). Fluoxetine at the dose of 30 mg/kg 
showed a tendency to reduce the MAO A and B 




Table 1: Effect of PLPE on the duration of immobility in rat tail suspension test (mean ± SD, n = 10) 
 
Group Dose (mg/kg) Duration of immobility (s) 
  Day 1 Day 7 Day 14 Control - 82.3±3.2 89.5±3.6 84.1±2.8 
Fluoxetine 30 64.2±1.9* 53.6±2.5* 54.8±2.7* 
PLPE-H 600 81.2±4.2 57.3±3.1 35.4±1.8** 
PLPE-M 300 79.3±3.1 69.2±2.6 47.1±1.9** 
PLPE-L 150 84.2±2.7 82.8±2.1 52.3±3.5* 
PLPE-H: High dose of PLPE; PLPE-M: Middle dose of PLPE; PLPE-L: Low dose of PLPE; *p < 0.05, 
**p < 0.01when compared with control groups 
 
Table 2: Effect of PLPE on duration of immobility in mouse forced-swimming test (mean ± SD, n = 10) 
 
Group Dose (mg/kg) Duration of immobility (s) 
  Day 1 Day 7 Day 14 Control - 79.6±2.5 75.3±2.7 77.0±2.9 
Fluoxetine 30 42.6±1.8* 35.2±1.4* 33.4±1.6** 
PLPE-H 600 73.5±2.3 52.4±1.7* 26.6±1.5** 
PLPE-M 300 76.4±1.9 71.3±2.2 34.3±1.7** 
PLPE-L 150 74.6±2.6 72.2±2.0 38.8±2.4* 
PLPE-H: High dose of PLPE; PLPE-M: Middle dose of PLPE; PLPE-L: Low dose of PLPE; *p<0.05, 
**p<0.01 when compared with control groups 
 
Table 3: Effect of PLPE on MAO activity in mouse whole brain (mean ± SD, n = 10) 
 
Group Dose (mg/kg) 




  A B A    B Control - 24.8±1.6 20.4±1.3 - - 
Fluoxetine 30 16.5±1.4 17.3±0.9 14.3 13.5 
PLPE-H 600 15.3±1.1** 18.3±1.4** 44.3 35.4 
PLPE-M 300 12.6±1.4** 16.5±0.8 34.7 14.2 
PLPE-L 150 10.7±1.3* 13.7±0.6 21.6 7.5 
PLPE-H: High dose of PLPE; PLPE-M: Middle dose of PLPE; PLPE-L: Low dose of PLPE; *p < 0.05, 
**p < 0.01when compared with control groups 
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The tail suspension and forced swimming tests 
are two behavioral tests in rodents that predict 
the clinical efficacy of many types of 
antidepressant treatments [8,9]. We studied 
PLPE on the immobility behaviors in rats. The 
extract at oral doses from 150 to 600 mg/kg for 
14 days significantly decreased the duration of 
immobility in the tail suspension test and the 
forced swimming test in rats. These behavioral 
effects of PLPE at the dose of 600 mg/kg were 
more potent than that of fluoxetine after 14-day 
treatment. Neither PLPE nor fluoxetine, at the 
doses tested, produced significant effects on 
locomotor activity. These data in the present 
study has shown that PLPE has antidepressant 
effects in rat models of immobility tests. 
 
MAO is an important enzyme in the metabolism 
of a wide range of monoamine neurotransmitters, 
including noradrenaline, dopamine, and 5-
hydroxytryptamine. MAO exists in two forms, A 
and B. MAO A is more important than MAO B in 
the metabolism of the major neurotransmitter 
monoamines. MAO A inhibitors have been 
accepted to treat depression [10,11]. In the 
present investigation, we have demonstrated that 
the extract of Paeonia lactiflora Pall. significantly 
inhibited in vivo MAO A activity in rat whole brain 
in a dose-dependent manner, however, only the 
extract at a dose up to 600 mg/kg exhibited MAO 
B inhibitory activity. These findings suggested 
that anti- depressant effects of Paeonia lactiflora 
Pall. in animal models of immobility tests may be 
related to the inhibitory activity of MAO, 




This study suggests that Paeonia lactiflora Pall. 
is a potential source of therapeutic substances 
for the treatment of depression, which would be 
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